| Recovery of replication-competent HIV despite prolonged suppression of plasma viremia JK Wong, M Hezareh, HF Günthard, DV Havlir, CC Ignacio, CA Spina, ... Science 278 (5341), 1291-1295, 1997 | 2107 | 1997 |
| Genetic variation in IL28B is associated with chronic hepatitis C and treatment failure: a genome-wide association study A Rauch, Z Kutalik, P Descombes, T Cai, J Di Iulio, T Mueller, M Bochud, ... Gastroenterology 138 (4), 1338-1345. e7, 2010 | 1313 | 2010 |
| 2011 update of the drug resistance mutations in HIV-1 VA Johnson, V Calvez, HF Günthard, R Paredes, D Pillay, R Shafer, ... Topics in antiviral medicine 19 (4), 156, 2011 | 1165 | 2011 |
| Update of the drug resistance mutations in HIV-1: December 2009 VA Johnson, F Brun-Vézinet, B Clotet, HF Gunthard, DR Kuritzkes, ... Top HIV Med 17 (5), 138-145, 2009 | 1163* | 2009 |
| 2011 update of the drug resistance mutations in HIV-1 VA Johnson, V Calvez, HF Günthard, R Paredes, D Pillay, R Shafer, ... Topics in antiviral medicine 19 (4), 156, 2011 | 1162 | 2011 |
| Antiretroviral treatment of adult HIV infection: 2010 recommendations of the International AIDS Society–USA panel MA Thompson, JA Aberg, P Cahn, JSG Montaner, G Rizzardini, A Telenti, ... Jama 304 (3), 321-333, 2010 | 1064 | 2010 |
| Antiretroviral treatment of adult HIV infection: 2010 recommendations of the International AIDS Society–USA panel MA Thompson, JA Aberg, P Cahn, JSG Montaner, G Rizzardini, A Telenti, ... Jama 304 (3), 321-333, 2010 | 1064 | 2010 |
| Antiretroviral treatment of adult HIV infection: 2012 recommendations of the International Antiviral Society–USA panel MA Thompson, JA Aberg, JF Hoy, A Telenti, C Benson, P Cahn, JJ Eron, ... Jama 308 (4), 387-402, 2012 | 995 | 2012 |
| Antiretroviral drug resistance testing in adult HIV-1 infection: 2008 recommendations of an International AIDS Society-USA panel MS Hirsch, HF Günthard, JM Schapiro, FB Vézinet, B Clotet, SM Hammer, ... Clinical Infectious Diseases 47 (2), 266-285, 2008 | 586 | 2008 |
| Delay of HIV-1 rebound after cessation of antiretroviral therapy through passive transfer of human neutralizing antibodies A Trkola, H Kuster, P Rusert, B Joos, M Fischer, C Leemann, A Manrique, ... Nature medicine 11 (6), 615-622, 2005 | 576 | 2005 |
| Antiretroviral treatment of adult HIV infection: 2014 recommendations of the International Antiviral Society–USA Panel HF Günthard, JA Aberg, JJ Eron, JF Hoy, A Telenti, CA Benson, ... Jama 312 (4), 410-425, 2014 | 532* | 2014 |
| Antiretroviral drugs for treatment and prevention of HIV infection in adults: 2016 recommendations of the International Antiviral Society–USA panel HF Günthard, MS Saag, CA Benson, C Del Rio, JJ Eron, JE Gallant, ... Jama 316 (2), 191-210, 2016 | 506 | 2016 |
| Prevalence and predictive value of intermittent viremia with combination HIV therapy DV Havlir, R Bassett, D Levitan, P Gilbert, P Tebas, AC Collier, MS Hirsch, ... Jama 286 (2), 171-179, 2001 | 414 | 2001 |
| Common genetic variation and the control of HIV-1 in humans J Fellay, D Ge, KV Shianna, S Colombo, B Ledergerber, ET Cirulli, ... PLoS genetics 5 (12), 2009 | 377 | 2009 |
| Effect of transmitted drug resistance on virological and immunological response to initial combination antiretroviral therapy for HIV (EuroCoord-CHAIN joint project): a … L Wittkop, HF Günthard, F De Wolf, D Dunn, A Cozzi-Lepri, A De Luca, ... The Lancet infectious diseases 11 (5), 363-371, 2011 | 363 | 2011 |
| 2019 update of the drug resistance mutations in HIV-1 AM Wensing, V Calvez, F Ceccherini-Silberstein, C Charpentier, ... Topics in antiviral medicine 27 (3), 111, 2019 | 355 | 2019 |
| Whole genome deep sequencing of HIV-1 reveals the impact of early minor variants upon immune recognition during acute infection MR Henn, CL Boutwell, P Charlebois, NJ Lennon, KA Power, ... PLoS pathogens 8 (3), 2012 | 324 | 2012 |
| Effect of treatment, during primary infection, on establishment and clearance of cellular reservoirs of HIV-1 MC Strain, SJ Little, ES Daar, DV Havlir, HF Günthard, RY Lam, OA Daly, ... The Journal of infectious diseases 191 (9), 1410-1418, 2005 | 320 | 2005 |
| Cohort profile: the Swiss HIV Cohort study Swiss HIV Cohort Study, F Schoeni-Affolter, B Ledergerber, ... International journal of epidemiology 39 (5), 1179-1189, 2010 | 312* | 2010 |
| Update of the drug resistance mutations in HIV-1: March 2013 VA Johnson, V Calvez, HF Günthard, R Paredes, D Pillay, RW Shafer, ... Topics in antiviral medicine 21 (1), 6, 2013 | 298 | 2013 |
Matthias CavassiniHead of the Infectious Diseases outpatient clinic, CHUV, Lausanne, SwitzerlandVerified email at chuv.ch
